Introduction
Otitis media continues to be one of the most common reasons for children to see a physician, affects virtually all children in one fashion or another and annually requires billions of dollars in healthcare expenditures for treatment. Antibiotic resistance has made otitis media treatment more challenging. Given all these factors, there continues to be a need for significantly more research into the pathophysiology, clinical management and outcomes of therapy of this disease process. Despite the fact that otitis media is relatively understudied, there are a number of areas in which significant progress has been made, and it is beyond the scope of this work to highlight or catalogue each of these areas. Instead, the focus of this manuscript will be to highlight some of the most important areas of recent investigation from both a basic science and clinical perspective.
Molecular biology
In the area of basic molecular biology, one of the most important advances has been the demonstration that otitis media, as a chronic infectious disease, represents a human pathologic condition associated with biofilm development. Although the concept that biofilms are the primary source of bacterial infection in chronic forms of otitis media is novel, the association of biofilms with other chronic forms of infection is certainly not [1] [2] [3] [4] . It has long been recognized that most bacteria in nature exist in a biofilm state as opposed to the small percentage of bacteria that live in a planktonic or free-swimming state. In the planktonic state, bacteria are capable of producing host responses that are generally associated with acute infections: fever, inflammation, cellular damage and leukocyte stimulation. However, pathologic conditions in which bacteria form biofilms also have numerous clinical implications. In the biofilm state, bacteria become organized, anchor to a surface and form a microcolony surrounded by a complex polymeric matrix that is constantly being remodeled, which includes polysaccharides, nucleic acids and proteins that are secreted by the bacteria themselves. Bacteria in the biofilm state maintain a low metabolic rate, are able to escape host immune surveillance and rapidly share genetic information. These characteristics make biofilm bacteria difficult to culture using standard techniques, difficult to eradicate with antimicrobial compounds and allows for the development of effective and widespread antimicrobial resistance characteristics. Evidence that chronic otitis media is the result of a biofilm infection has been demonstrated by a number of well designed studies [5, 6] . However, recent identification of bacterial biofilms in children with recurrent acute otitis media (RecOM) and
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chronic otitis media with effusion (OME), and not in control populations [7 ] , has brought this otitis media biofilm discussion from a basic science, theoretical discussion to a clinical one. With the demonstration of biofilms in children with chronic otitis media, and the likelihood that these biofilms play a role in the pathogenesis of otitis media, important clinical questions require additional scrutiny. What are the implications for otitis media treatment and pathogen eradication with the knowledge that middle ear pathogens routinely achieve biofilm formation and that this environment enhances their ability to develop and acquire antimicrobial resistance? Early onset of otitis media increases the likelihood of developing chronic disease; what are the implications of biofilm formation in these patients and the best strategies for prevention? What will be the clinical impact of antibiofilm interventions? As middle ear biofilms likely originate in the nasopharynx, this may include strategies such as reduction of nasopharyngeal biofilm through surgical (adenoidectomy), mechanical or pharmacologic (nasal irrigations or medications designed to reduce biofilm formation) means. With respect to RecOM, the somewhat unexpected finding of biofilms in each of the patients with chronic RecOM also raises important questions with respect to pathogenesis. It has been postulated that each of these recurrent infections represent a new episode caused by a unique bacterial strain ascending through the nasopharynx and Eustachian tube into the middle ear space [8] . However, these findings would suggest that viable bacteria are capable of residing as biofilms within the middle ear space in between acute exacerbations of bacterial infection and, at least in part, may be responsible for the recrudescence of these acute infections through planktonic showering of bacteria from the biofilm. Other studies would support this hypothesis and have demonstrated that approximately 30% of cases of recurrent otitis media result from relapses attributable to the original organism [8] . In addition, surgical intervention with tympanostomy tubes for patients with RecOM and OME, known to be clinically efficacious, will need further examination with a biofilm concept of pathogenesis. This includes not only initial placement of tympanostomy tubes but also potential complications such as chronic otorrhea from tympanostomy tubes [9 ] .
It is important to point out that the findings from these studies do not exclude other potential pathogenic factors associated with chronic otitis media. Important associations such as an antecedent viral upper respiratory infection, Eustachian tube dysfunction, a genetically predisposed host, persistent inflammatory mediators or exacerbation by gastroesophageal reflux could each be incorporated into the concept of facilitating biofilm formation. Although these factors may also be independently associated with otitis media chronicity, the ubi-quitous presence of biofilms in patients with chronic otitis media would suggest that investigations aimed at linking these factors to biofilm formation may provide significant scientific advances toward understanding chronic otitis media and developing novel treatment regimens.
Developmental impact, outcomes and quality of life in patients with otitis media
Studies examining outcomes of patients with otitis media have been extremely important in recent years. One of the most important areas of discussion has centered around the potential long-term impact on childhood development in children with chronic OME. In a recently published study following children for a long term [10 ] , 6350 infants were enrolled after birth. Subsequently, 429 healthy kids developed persistent middle ear effusion (MEE) and were randomized before 3 years of age to undergo bilateral tympanostomy tube placement promptly or to wait 9 months and undergo tympanostomy tube placement if the effusion was still present. Of these children, 391 were then assessed for literacy, attention, social skills and academic achievement at 9-11 years of age. This study did not find a difference between patients who received prompt intervention with tympanostomy tubes and those who received them later. Unfortunately, data from this study had been often misinterpreted and led to erroneous clinical assumptions not supported by the evidence presented in the study. The authors are careful to point out that their findings cannot be generalized to children who are not otherwise healthy or have disabilities such as sensorineural hearing loss, speech delay or Down's syndrome or to children in whom effusion is consistently accompanied by levels of hearing loss higher than those in the study. And although patients with these types of characteristics are relatively rare in the general population, they are quite common in the group of patients who are referred for surgical consideration. In a recent review of surgical patients, 50% of 168 children had developmental delays prior to tube placement and would have been at a risk not eligible for the above study. In addition to this, there are a number of methodological aspects of this data set that need consideration before making the assumption that even healthy children do not benefit from early intervention with tympanostomy tubes. Only a small percentage of patients studied had bilateral MEE for more than 90 days (27%), whereas 60% had unilateral effusions. Obviously, patients with unilateral disease would be expected to have normal hearing in the unaffected ear, and these patients would not be expected to demonstrate developmental delays even if treatment were delayed. In contrast, in a recent examination of children undergoing surgical intervention for OME, these patients had much more severe disease, with 86% having bilateral MEE and an additional 10% demonstrating bilateral ear disease related to changes in the tympanic membrane associated with retraction [11] . An important point not evident from cursory examination of the patient set is that 50% of the patients originally randomized into the delayed group crossed over to the treatment group in less than 9 months because of parental preference. This almost undoubtedly represents a significant bias in the patient analysis given that the most likely factors influencing patient crossover would be more severe or progressive disease, removing the most severely affected patients from the observational group. In addition, it needs to be mentioned that a majority of patients (56%) who are referred for surgical intervention for OME are also affected by RecOM as an additional consideration for tympanostomy tube placement [11] . Other studies have demonstrated some likelihood that otitis media may affect development [12, 13] , and importantly, these tended to be larger population studies which did not aggressively screen for patient enrollment, therefore, more likely capturing patients who would ordinarily present to a physician with disease. One such study demonstrated that children with otitis media had poorer receptive and expressive language at an age of 2-5 years (P < 0.01) [14] . Finally, a number of studies have demonstrated conclusively that children with otitis media and OME benefit significantly from surgical intervention with improved quality of life [15 ,16] . Taken in aggregate, these data can most appropriately be summarized as: healthy children enrolled in a study with aggressive screening procedures to identify children who develop MEE and with minimal difficulty from MEE, such as unilateral fluid, and without significant other health considerations are not likely to have significant developmental delays if monitored closely without surgical intervention. However, more significantly affected children are likely to benefit from surgical intervention and have significant improvement in their quality of life. Fortunately, studies examining patients undergoing surgical intervention, which are more likely to demonstrate realworld practice patterns, indicate that referred patients and those operated upon have a much higher severity of disease and other associated medical conditions.
Surgical outcomes
One additional area to address within the realm of outcomes is surgical outcomes. Tympanostomy tube placement is the most common surgical procedure performed in children apart from circumcision. Despite over a million procedures being performed in the United States alone, very few data exist with respect to the variety of surgical techniques and procedures. As with any surgical procedure, tympanostomy tube placement does have the potential for morbidity. These are generally small difficulties, but this procedure has been associated with hearing loss, retained tubes which require removal, tympanic membrane perforation and cholesteatoma formation. Studies examining the risk of tympanic membrane perforation have identified that longer lasting tympanostomy tubes such as T-tubes present an increase in risk of perforation. Additional retrospective studies have analyzed specific types of tubes that remain for a shorter period of time, such as Armstrong beveled bobbin tubes, and have found them to be well tolerated without any significant incidence of complication [17] . However, large, prospective studies examining surgical outcomes that have been lacking are currently underway [18] .
Vaccines
An additional area of fertile investigation with respect to otitis media is in the arena of vaccine development. This area of investigation has included both viral and bacterial vaccine development, given that many episodes of bacterial otitis media are preceded by a viral upper respiratory tract infection. Of the major upper respiratory viral pathogens associated with otitis media, only the influenza vaccine has been reliably tested and demonstrated to have the potential to reduce otitis media episodes [19] . Similarly, although there exists promise for the development of bacterial vaccines against the major otitis media bacterial pathogens, the results to date have been somewhat limited. The only major otitis media pathogen to achieve successful vaccination has been for that of Streptococcus pneumoniae, and although the pneumococcal conjugate vaccine has provided improved immunogenicity as compared with previous pneumococcal vaccines, it has provided only modest reduction in otitis media episodes in the range of 6-7% [20] . This has been related to the fact that, even in vaccinated children, the efficacy of the vaccine is somewhat lacking, and a relatively high rate of infection can occur with the serotypes covered by the vaccine [21] . Additionally, the conjugate vaccine utilized in the United States is only a heptavalent vaccine. Although it is designed to protect against the serotypes most likely to demonstrate antimicrobial resistance, it has been demonstrated that following vaccination, the nasopharynx of children becomes colonized with other serotypes of pneumococcus that also have the potential for pathogenesis and development of antimicrobial resistance [22 ,23 ] .
Of clinical importance along with the widespread utilization of the pneumococcal conjugate vaccine is also the increased incidence of nontypeable Haemophilus influenzae (NTHi) otitis media infections. Given this increased incidence and the overall association of NTHi with the development of chronic otitis media, ongoing efforts at developing NTHi vaccines have moved forward. It is beyond the scope of this manuscript to outline all the promising venues in this research. However, one interesting development is the utilization of protein D, which has demonstrated efficacy in limiting both pneumococcal and NTHi otitis media in both animal and a recent human trial [24 ] . It is clear that significant progress continues to be made in many other areas as well [25 ,26 ] , and that development of an effective NTHi vaccine will reach fruition, which, in turn, will have a major impact on the management of otitis media.
Risk factors and otitis media
Another area of some progress in the field of otitis media has been the assessment of risk factors in patients. Along with a better understanding of pathogenesis and the development of new vaccine strategies, this perhaps holds the greatest promise in allowing clinicians to effectively manage patients with otitis media. In the discussion about which patients benefit from surgical intervention compared with watchful waiting, it is clear that patients with elevated risk for developmental delay, speech delay or who have other medical problems should be managed differently than children without these difficulties. Thoughtful investigations to more clearly define the parameters around these clinical decisions are important. Additionally, the concept of risk assessment has allowed for a more individualized approach in the management of acute otitis media (AOM). With an understanding that a large percentage of episodes of AOM can resolve spontaneously and that there are differences in managing risks associated with AOM on the basis of patient age [27] , there has been a trend toward fewer antibiotic prescriptions and managing, especially older children, expectantly, with utilization of antimicrobial therapy in AOM for younger children and those without resolution of symptoms in 1-2 days.
Additionally, genomic characterization of individuals holds great potential to allow clinicians to make individual decisions for patients in the future. It has been demonstrated conclusively that there is a strong genetic component to susceptibility and likely morbidity associated with otitis media [28] . Undoubtedly, there are many genetic factors that are implicated in otitis media, which will make deciphering the role of any specific gene complex. Added to this complexity is the certainty that environmental influences such as daycare attendance will interact with genetic predisposition. However, genomewide linkage studies and investigation of specific candidate genes are providing insight into possible areas of therapeutic investigation [29] . Some of the most interesting investigations have included findings demonstrating that genetic polymorphisms are associated with inflammatory cytokines or mucin genes, both known to be important in the pathogenesis of otitis media, in patients who are prone to otitis media [30,31 ,32] . This type of patient-specific knowledge about genetic susceptibility will lead to an entirely new arena of individualized medicine in which specific clinical decisions about the benefits of antimicrobial therapy or surgical intervention will be possible, based upon genetic predisposition characteristics.
Conclusion
In summary, we have highlighted a number of recent important topics of conversation and areas of investigation with respect to otitis media. Given the prevalence of this disease in childhood and the diversity with which patients present and are currently managed, there remains a great deal of work ahead to solidify our understanding of otitis media pathogenesis and optimum treatment practices. However, with continued investment in otitis media research to sustain current energetic investigations, and those of the future, it appears clear that there are numerous opportunities for clinical advancement in the near future.
